Lipid metabolism in chronic obstructive pulmonary disease

References

• Lochner M, Berod L, Sparwasser T. Fatty acid metabolism in the regulation of T cell function. Trends Immunol. 2015;36(2):81–91. doi:10.1016/j.it.2014.12.00525592731
   PubMed Web of Science ®Google Scholar
• Walther TC, Farese RV Jr. Lipid droplets and cellular lipid metabolism. Annu Rev Biochem. 2012;81:687–714. doi:10.1146/annurev-biochem-061009-10243022524315
   PubMed Web of Science ®Google Scholar
• Lane-Donovan C, Philips GT, Herz J. More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron. 2014;83(4):771–787. doi:10.1016/j.neuron.2014.08.00525144875
   PubMed Web of Science ®Google Scholar
• Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9(2):162–176. doi:10.1038/nrm233518216772
   PubMed Web of Science ®Google Scholar
• Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology – divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710–730. doi:10.1038/nrendo.2017.9128849786
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20. doi:10.1016/j.cmet.2007.10.00218177721
   PubMed Web of Science ®Google Scholar
• Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. doi:10.1016/j.cmet.2013.05.01723791484
   PubMed Web of Science ®Google Scholar
• Alvarado A, Arce I. Metabolic functions of the lung, disorders and associated pathologies. J Clin Med Res. 2016;8(10):689–700. doi:10.14740/jocmr2668w27635172
   PubMedGoogle Scholar
• Lamonaca P, Prinzi G, Kisialiou A, Cardaci V, Fini M, Russo P. Metabolic disorder in Chronic Obstructive Pulmonary Disease (COPD) patients: towards a personalized approach using marine drug derivatives. Mar Drugs. 2017;15(3). doi:10.3390/md15030081
   Web of Science ®Google Scholar
• Kilk K, Aug A, Ottas A, Soomets U, Altraja S, Altraja A. Phenotyping of chronic obstructive pulmonary disease based on the integration of metabolomes and clinical characteristics. Int J Mol Sci. 2018;19(3):666. doi:10.3390/ijms19030666
   PubMed Web of Science ®Google Scholar
• Yedgar S, Krimsky M, Cohen Y, Flower RJ. Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol Sci. 2007;28(9):459–464. doi:10.1016/j.tips.2007.07.00517692394
   PubMed Web of Science ®Google Scholar
• Coxson HO, Chan IHT, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med. 2004;170(7):748–752. doi:10.1164/rccm.200405-651OC15256394
   PubMed Web of Science ®Google Scholar
• Gail DB, Massaro GD, Massaro D. Influence of fasting on the lung. J Appl Physiol. 1977;42(1):88–92. doi:10.1152/jappl.1977.42.1.88188800
   PubMed Web of Science ®Google Scholar
• D‘Amours R, Clerch L, Massaro D. Food deprivation and surfactant in adult rats. J Appl Physiol. 1983;55(5):1413–1417. doi:10.1152/jappl.1983.55.5.14136689008
   PubMed Web of Science ®Google Scholar
• Sahebjami H, MacGee J. Effects of starvation on lung mechanics and biochemistry in young and old rats. J Appl Physiol. 1985;58(3):778–784. doi:10.1152/jappl.1985.58.3.7783156843
   PubMed Web of Science ®Google Scholar
• Sahebjami H, Vassallo CL, Wirman JA. Lung mechanics and ultrastructure in prolonged starvation. Am Rev Respir Dis. 1978;117(1):77–83. doi:10.1164/arrd.1978.117.1.77619728
   PubMed Web of Science ®Google Scholar
• Sahebjami H, Wirman JA. Emphysema-like changes in the lungs of starved rats. Am Rev Respir Dis. 1981;124(5):619–624. doi:10.1164/arrd.1981.124.5.6197305117
   PubMed Web of Science ®Google Scholar
• Kerr JS, Riley DJ, Lanza-Jacoby S, et al. Nutritional emphysema in the rat. Influence of protein depletion and impaired lung growth. Am Rev Respir Dis. 1985;131(4):644–650. doi:10.1164/arrd.1985.131.4.6443873194
   PubMed Web of Science ®Google Scholar
• Lambert AA, Putcha N, Drummond MB, et al. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017;151(1):68–77. doi:10.1016/j.chest.2016.08.143227568229
   PubMed Web of Science ®Google Scholar
• Hanson C, Rutten EP, Wouters EF, Rennard S. Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:723–733. doi:10.2147/COPD.S5011125125974
   PubMed Web of Science ®Google Scholar
• Agarwal AR, Yin F, Cadenas E. Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol. 2014;51(2):284–293. doi:10.1165/rcmb.2013-0523OC24625219
   PubMed Web of Science ®Google Scholar
• Titz B, Boue S, Phillips B, et al. Effects of cigarette smoke, cessation, and switching to two heat-not-burn tobacco products on lung lipid metabolism in C57BL/6 and Apoe-/- mice – an integrative systems toxicology analysis. Toxicol Sci. 2016;149(2):441–457. doi:10.1093/toxsci/kfv24426582801
   PubMed Web of Science ®Google Scholar
• Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227–232. doi:10.1038/nrc348323446547
   PubMed Web of Science ®Google Scholar
• Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7:e2226. doi:10.1038/cddis.2016.13227195673
   PubMed Web of Science ®Google Scholar
• Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422–2435. doi:10.1016/j.bbamcr.2016.01.02326828774
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11–31. doi:10.1038/nrclinonc.2016.6027141887
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-928513453
   PubMed Web of Science ®Google Scholar
• Agarwal AR, Zhao LQ, Sancheti H, Sundar IK, Rahman I, Cadenas E. Short-term cigarette smoke exposure induces reversible changes in energy metabolism and cellular redox status independent of inflammatory responses in mouse lungs. Am J Physiol-Lung Cell Mol Physiol. 2012;303(10):L889–L898. doi:10.1152/ajplung.00219.201223064950
   PubMed Web of Science ®Google Scholar
• Jiang Z, Knudsen NH, Wang G, et al. Genetic control of fatty acid beta-oxidation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2017;56(6):738–748. doi:10.1165/rcmb.2016-0282OC28199134
   PubMed Web of Science ®Google Scholar
• Conlon TM, Bartel J, Ballweg K, et al. Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema. Clin Sci. 2016;130(4):273–287. doi:10.1042/CS2015043826564208
   PubMed Web of Science ®Google Scholar
• More JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med. 2010;10:53. doi:10.1186/1471-2466-10-5320973980
   PubMed Web of Science ®Google Scholar
• Ohlmeier S, Vuolanto M, Toljamo T, et al. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res. 2008;7(12):5125–5132. doi:10.1021/pr800423x19367700
   PubMed Web of Science ®Google Scholar
• Michaeloudes C, Kuo CH, Haji G, et al. Metabolic re-patterning in COPD airway smooth muscle cells. Eur Respir J. 2017;50(5). doi:10.1183/13993003.00711-2017.
   Web of Science ®Google Scholar
• Leslie CC. Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol. 2004;82(1):1–17. doi:10.1139/o03-08015052324
   PubMed Web of Science ®Google Scholar
• Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002;61(3):345–358.12296294
   PubMed Web of Science ®Google Scholar
• Ferrer R, Moreno JJ. Role of eicosanoids on intestinal epithelial homeostasis. Biochem Pharmacol. 2010;80(4):431–438. doi:10.1016/j.bcp.2010.04.03320457139
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–1875.11729303
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology. 2008;13(7):1014–1021. doi:10.1111/j.1440-1843.2008.01365.x18699805
   PubMed Web of Science ®Google Scholar
• Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax. 2003;58(7):585–588.12832671
   PubMed Web of Science ®Google Scholar
• Dagouassat M, Gagliolo JM, Chrusciel S, et al. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013;187(7):703–714. doi:10.1164/rccm.201208-1361OC23328527
   PubMed Web of Science ®Google Scholar
• Drakatos P, Lykouras D, Sampsonas F, Karkoulias K, Spiropoulos K. Targeting leukotrienes for the treatment of COPD? Inflamm Allergy Drug Targets. 2009;8(4):297–306. doi:10.2174/18715280978935217719754414
   PubMedGoogle Scholar
• Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest. 2003;123(4):1240–1247.12684317
   PubMed Web of Science ®Google Scholar
• Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax. 2003;58(4):294–298.12668789
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. doi:10.1038/nature1347924899309
   PubMed Web of Science ®Google Scholar
• Hsiao HM, Thatcher TH, Colas RA, Serhan CN, Phipps RP, Sime PJ. Resolvin D1 reduces emphysema and chronic inflammation. Am J Pathol. 2015;185(12):3189–3201. doi:10.1016/j.ajpath.2015.08.00826468975
   PubMed Web of Science ®Google Scholar
• Pena KB, Ramos CO, Soares NP, et al. The administration of a high refined carbohydrate diet promoted an increase in pulmonary inflammation and oxidative stress in mice exposed to cigarette smoke. Int J Chron Obstruct Pulmon Dis. 2016;11:3207–3217. doi:10.2147/COPD.S11948528008246
   PubMed Web of Science ®Google Scholar
• Croasdell A, Thatcher TH, Kottmann RM, et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am J Physiol Lung Cell Mol Physiol. 2015;309(8):L888–L901. doi:10.1152/ajplung.00125.201526301452
   PubMed Web of Science ®Google Scholar
• Reddy AT, Lakshmi SP, Muchumarri RR, Reddy RC. Nitrated fatty acids reverse cigarette smoke-induced alveolar macrophage activation and inhibit protease activity via electrophilic S-Alkylation. PLoS One. 2016;11(4):e0153336. doi:10.1371/journal.pone.015333627119365
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• O‘Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–565. doi:10.1038/nri.2016.7027396447
   PubMed Web of Science ®Google Scholar
• Kim KH. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu Rev Nutr. 1997;17:77–99. doi:10.1146/annurev.nutr.17.1.779240920
   PubMed Web of Science ®Google Scholar
• Smith S, Witkowski A, Joshi AK. Structural and functional organization of the animal fatty acid synthase. Prog Lipid Res. 2003;42(4):289–317.12689621
   PubMed Web of Science ®Google Scholar
• Britto CJ, Brady V, Lee S, Dela Cruz CS. Respiratory viral infections in chronic lung diseases. Clin Chest Med. 2017;38(1):87–96. doi:10.1016/j.ccm.2016.11.01428159164
   PubMed Web of Science ®Google Scholar
• Nguyen A, Guedan A, Mousnier A, et al. Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targets. J Lipid Res. 2018;59(9):1671–1684. doi:10.1194/jlr.M08591029946055
   PubMed Web of Science ®Google Scholar
• Rahman SM, Ji X, Zimmerman LJ, et al. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight. 2016;1(19):e88814. doi:10.1172/jci.insight.8881427882349
   PubMed Web of Science ®Google Scholar
• Solanki HS, Babu N, Jain AP, et al. Cigarette smoke induces mitochondrial metabolic reprogramming in lung cells. Mitochondrion. 2018;40:58–70. doi:10.1016/j.mito.2017.10.00229042306
   PubMed Web of Science ®Google Scholar
• Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013;13(4):233–245. doi:10.1038/nrc347723467302
   PubMed Web of Science ®Google Scholar
• Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007;17(7):318–324. doi:10.1016/j.tcb.2007.07.00417658261
   PubMed Web of Science ®Google Scholar
• DeBose-Boyd RA, Ye J. SREBPs in lipid metabolism, insulin signaling, and beyond. Trends Biochem Sci. 2018;43:358–368. doi:10.1016/j.tibs.2018.01.00529500098
   PubMed Web of Science ®Google Scholar
• Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discovery. 2014;13(6):433–444. doi:10.1038/nrd428024833295
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289–312. doi:10.1146/annurev.biochem.77.061307.09182918518822
   PubMed Web of Science ®Google Scholar
• Lakshmi SP, Reddy AT, Zhang Y, et al. Down-regulated peroxisome proliferator-activated receptor gamma (PPARgamma) in lung epithelial cells promotes a PPARgamma agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). J Biol Chem. 2014;289(10):6383–6393. doi:10.1074/jbc.M113.53680524368768
   PubMed Web of Science ®Google Scholar
• Shan M, You R, Yuan X, et al. Agonistic induction of PPARgamma reverses cigarette smoke-induced emphysema. J Clin Invest. 2014;124(3):1371–1381. doi:10.1172/JCI7058724569375
   PubMed Web of Science ®Google Scholar
• Solleti SK, Simon DM, Srisuma S, et al. Airway epithelial cell PPARgamma modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice. Am J Physiol Lung Cell Mol Physiol. 2015;309(3):L293–L304. doi:10.1152/ajplung.00287.201426024894
   PubMed Web of Science ®Google Scholar
• Lea S, Plumb J, Metcalfe H, et al. The effect of peroxisome proliferator-activated receptor- ligands on in vitro and in vivo models of COPD. Eur Respir J. 2013;43(2):409–420. doi:10.1183/09031936.0018781223794466
   PubMed Web of Science ®Google Scholar
• Morissette MC, Shen P, Thayaparan D, Stampfli MR. Impacts of peroxisome proliferator-activated receptor-gamma activation on cigarette smoke-induced exacerbated response to bacteria. Eur Respir J. 2015;45(1):191–200. doi:10.1183/09031936.0000431425034559
   PubMed Web of Science ®Google Scholar
• Higham A, Lea S, Plumb J, et al. The role of the liver X receptor in chronic obstructive pulmonary disease. Respir Res. 2013;14:106. doi:10.1186/1465-9921-14-1924118845
   PubMed Web of Science ®Google Scholar
• Besnard V, Wert SE, Stahlman MT, et al. Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts. J Biol Chem. 2009;284(6):4018–4030. doi:10.1074/jbc.M80538820019074148
   PubMed Web of Science ®Google Scholar
• Yuan H, Shyy JYJ, Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol. 2009;51(3):535–547. doi:10.1016/j.jhep.2009.03.02619556020
   PubMed Web of Science ®Google Scholar
• Chang TY, Chang CC, Ohgami N, Yamauchi Y. Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol. 2006;22:129–157. doi:10.1146/annurev.cellbio.22.010305.10465616753029
   PubMed Web of Science ®Google Scholar
• Spann NJ, Glass CK. Sterols and oxysterols in immune cell function. Nat Immunol. 2013;14(9):893–900. doi:10.1038/ni.268123959186
   PubMed Web of Science ®Google Scholar
• Brown MS, Radhakrishnan A, Goldstein JL. Retrospective on cholesterol homeostasis: the central role of scap. Annu Rev Biochem.  2018;87:783–807.
   Web of Science ®Google Scholar
• Zafirova-Ivanovska B, Stojkovikj J, Dokikj D, et al. The level of cholesterol in COPD patients with severe and very severe stage of the disease. Open Access Maced J Med Sci. 2016;4(2):277–282. doi:10.3889/oamjms.2016.06327335600
   PubMedGoogle Scholar
• Li H, Liu Y, Wang L, et al. High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease. Lipids Health Dis. 2016;15:59. doi:10.1186/s12944-016-0228-127001252
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Sugiura H, Koarai A, et al. Increase of 27-hydroxycholesterol in the airways of patients with COPD: possible role of 27-hydroxycholesterol in tissue fibrosis. Chest. 2012;142(2):329–337. doi:10.1378/chest.11-209122281802
   PubMed Web of Science ®Google Scholar
• Jia J, Conlon TM, Sarker RS, et al. Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease. EMBO Mol Med. 2018;10:5. doi:10.15252/emmm.201708349
   Web of Science ®Google Scholar
• Mroz RM, Lisowski P, Tycinska A, et al. Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study. J Physiol Pharmacol. 2015;66(1):111–128.25716971
   PubMed Web of Science ®Google Scholar
• Davis BB, Zeki AA, Bratt JM, et al. Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J. 2013;42(2):350–361. doi:10.1183/09031936.0004251223180589
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Sugiura H, Togo S, et al. 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells. Am J Physiol Lung Cell Mol Physiol. 2016;310(11):L1028–L1041. doi:10.1152/ajplung.00351.201527036870
   PubMed Web of Science ®Google Scholar
• Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298(6676):784–788.2496857
   PubMed Web of Science ®Google Scholar
• Mjos OD. Lipid effects of smoking. Am Heart J. 1988;115(1 Pt 2):272–275. doi:10.1016/0002-8703(88)90649-73336994
   PubMed Web of Science ®Google Scholar
• Kim C, Lee J-M, Park S-W, et al. Attenuation of cigarette smoke-induced emphysema in mice by apolipoprotein A-1 overexpression. Am J Respir Cell Mol Biol. 2016;54(1):91–102. doi:10.1165/rcmb.2014-0305OC26086425
   PubMed Web of Science ®Google Scholar
• Thomson NC. Clinical studies of statins in asthma and COPD. Curr Mol Pharmacol. 2017;10(1):60–71. doi:10.2174/187446720966616011212591126758945
   PubMed Web of Science ®Google Scholar
• Telenga ED, Hoffmann RF, Ruben TK, et al. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids. Am J Respir Crit Care Med. 2014;190(2):155–164. doi:10.1164/rccm.201312-2210OC24871890
   PubMed Web of Science ®Google Scholar
• Bowler RP, Jacobson S, Cruickshank C, et al. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med. 2015;191(3):275–284. doi:10.1164/rccm.201410-1771OC25494452
   PubMed Web of Science ®Google Scholar
• Chalfant CE, Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005;118(Pt 20):4605–4612. doi:10.1242/jcs.0263716219683
   PubMed Web of Science ®Google Scholar
• Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11(5):491–498. doi:10.1038/nm123815852018
   PubMed Web of Science ®Google Scholar
• Schweitzer KS, Hatoum H, Brown MB, et al. Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol. 2011;301(6):L836–L846. doi:10.1152/ajplung.00385.201021873444
   PubMed Web of Science ®Google Scholar
• Mizumura K, Justice MJ, Schweitzer KS, et al. Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure. FASEB J. 2018;32(4):1880–1890. doi:10.1096/fj.201700571R29196503
   PubMed Web of Science ®Google Scholar
• Baudiß K, Ayata CK, Lazar Z, et al. Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation. Eur Respir J. 2015;45(6):1669–1680. doi:10.1183/09031936.0008001425614161
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1(1):73–83. doi:10.1016/S2213-2600(12)70060-724321806
   PubMed Web of Science ®Google Scholar
• Vanfleteren L, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016;4(11):911–924. doi:10.1016/S2213-2600(16)00097-727264777
   PubMed Web of Science ®Google Scholar
• Kelly B, O‘Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25(7):771–784. doi:10.1038/cr.2015.6826045163
   PubMed Web of Science ®Google Scholar
• King TE Jr, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis. 1988;158(6):1309–1316.3143765
   PubMed Web of Science ®Google Scholar
• Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006;194(10):1375–1384. doi:10.1086/50842817054066
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol. 2010;11(8):593–598. doi:10.1038/nrm293420606693
   PubMed Web of Science ®Google Scholar
• Wenk MR. Lipidomics: new tools and applications. Cell. 2010;143(6):888–895. doi:10.1016/j.cell.2010.11.03321145456
   PubMed Web of Science ®Google Scholar
• Guijas C, Montenegro-Burke JR, Warth B, Spilker ME, Siuzdak G. Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol. 2018;36(4):316–320. doi:10.1038/nbt.410129621222
   PubMed Web of Science ®Google Scholar